{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:03:54Z","timestamp":1786122234040,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,26]],"date-time":"2027-06-26T00:00:00Z","timestamp":1813968000000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["1R56HL157579-01"],"award-info":[{"award-number":["1R56HL157579-01"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL148191"],"award-info":[{"award-number":["R01HL148191"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["T32HL105324"],"award-info":[{"award-number":["T32HL105324"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM115428"],"award-info":[{"award-number":["U54GM115428"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1P20 GM104357"],"award-info":[{"award-number":["1P20 GM104357"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.placenta.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:20:48Z","timestamp":1781994048000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-2810","authenticated-orcid":false,"given":"Adrian C.","family":"Eddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavisha A.","family":"Bakrania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Rajakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey P.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-7433","authenticated-orcid":false,"given":"Sarosh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib1","first-page":"1","article-title":"ACOG practice bulletin no. 202 summary: gestational hypertension and Preeclampsia","volume":"133","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.06.010_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2458-5-131","article-title":"National estimates for maternal mortality: an analysis based on the WHO systematic review of maternal mortality and morbidity","volume":"5","author":"Betr\u00e1n","year":"2005","journal-title":"BMC Public Health"},{"issue":"9726","key":"10.1016\/j.placenta.2026.06.010_bib3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(10)60518-1","article-title":"Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium development goal 5","volume":"375","author":"Hogan","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.placenta.2026.06.010_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S0965539511000040","article-title":"Seizures in women with Preeclampsia: mechanisms and management","volume":"22","author":"Cipolla","year":"2011","journal-title":"Fetal Matern. Med. Rev."},{"issue":"7","key":"10.1016\/j.placenta.2026.06.010_bib5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.placenta.2026.06.010_bib6","doi-asserted-by":"crossref","first-page":"4108271","DOI":"10.1155\/2019\/4108271","article-title":"Early- and late-onset preeclampsia: a comprehensive cohort study of laboratory and clinical findings according to the new ISHHP criteria","volume":"2019","author":"W\u00f3jtowicz","year":"2019","journal-title":"Int. J. Hypertens."},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/cs1040413","article-title":"Pre-eclampsia and the microcirculation: a novel explanation","volume":"104","author":"Bates","year":"2003","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.placenta.2026.06.010_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0143-4004(81)80042-2","article-title":"Review article: trophoblast invasion and the establishment of hemochorial placentation","volume":"2","author":"Pijnenborg","year":"1981","journal-title":"Placenta"},{"issue":"8","key":"10.1016\/j.placenta.2026.06.010_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","article-title":"A critical review of early-onset and late-onset preeclampsia","volume":"66","author":"Raymond","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"issue":"5","key":"10.1016\/j.placenta.2026.06.010_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.placenta.2026.06.010_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11936-018-0653-8","article-title":"Hypertensive disorders of pregnancy and cardiovascular diseases: current knowledge and future directions","volume":"20","author":"Coutinho","year":"2018","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.ajkd.2017.01.002","article-title":"Preeclampsia and the long-term risk of kidney failure","volume":"69","author":"Hildebrand","year":"2017","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tem.2004.03.002","article-title":"The developmental origins of the metabolic syndrome","volume":"15","author":"Gluckman","year":"2004","journal-title":"Trends Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.placenta.2026.06.010_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.STR.0000254471.72186.03","article-title":"Infant growth and stroke in adult life","volume":"38","author":"Osmond","year":"2007","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.placenta.2026.06.010_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","article-title":"Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR","volume":"226","author":"Kendall","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.placenta.2026.06.010_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13293-018-0195-5","article-title":"Pro-angiogenic therapeutics for preeclampsia","volume":"9","author":"Eddy","year":"2018","journal-title":"Biol. Sex Differ."},{"issue":"11","key":"10.1016\/j.placenta.2026.06.010_bib18","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","article-title":"Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia","volume":"145","author":"Nagamatsu","year":"2004","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.placenta.2026.06.010_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ajh.2009.24","article-title":"Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats","volume":"22","author":"Bridges","year":"2009","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ajog.2016.03.001","article-title":"Placental origins of adverse pregnancy outcomes: potential molecular targets: an executive workshop summary of the Eunice kennedy shriver national institute of child health and human development","volume":"215","author":"Ilekis","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.placenta.2026.06.010_bib21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","volume":"95","author":"Ahmad","year":"2004","journal-title":"Circ. Res."},{"issue":"6B","key":"10.1016\/j.placenta.2026.06.010_bib22","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1582-4934.2009.00820.x","article-title":"Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model","volume":"14","author":"Bergmann","year":"2010","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.placenta.2026.06.010_bib25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.2015020157","article-title":"Removal of soluble fms-like tyrosine Kinase-1 by dextran sulfate apheresis in preeclampsia","volume":"27","author":"Thadhani","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.placenta.2026.06.010_bib26","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.placenta.2026.06.010_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-026-04333-6","article-title":"Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial","author":"Thadhani","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.placenta.2026.06.010_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jep.2018.05.019","article-title":"Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies","volume":"225","author":"Aziz","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.placenta.2026.06.010_bib29","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156800908786241050","article-title":"Luteolin, a flavonoid with potential for cancer prevention and therapy","volume":"8","author":"Lin","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ptr.3305","article-title":"Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress","volume":"25","author":"Liu","year":"2011","journal-title":"Phytother Res."},{"issue":"Suppl 9B","key":"10.1016\/j.placenta.2026.06.010_bib31","doi-asserted-by":"crossref","first-page":"71s","DOI":"10.1016\/S0002-9343(01)00995-0","article-title":"Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer","volume":"113","author":"Kris-Etherton","year":"2002","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.placenta.2026.06.010_bib32","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300611R","article-title":"Bioflavonoid luteolin prevents sFlt-1 release via HIF-1\u03b1 inhibition in cultured human placenta","volume":"37","author":"Eddy","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.placenta.2026.06.010_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.preghy.2020.10.008","article-title":"Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats","volume":"23","author":"Yang","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.placenta.2026.06.010_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.placenta.2023.12.004","article-title":"Luteolin prevents TNF-\u03b1-induced NF-\u03baB activation and ROS production in cultured human placental explants and endothelial cells","volume":"145","author":"Eddy","year":"2023","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.placenta.2026.06.010_bib35","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.107.096594","article-title":"Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression","volume":"50","author":"Gilbert","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/HYPERTENSIONAHA.119.13368","article-title":"Biopolymer-delivered, maternally sequestered NF-\u03baB (Nuclear Factor-\u03baB) inhibitory peptide for treatment of Preeclampsia","volume":"75","author":"Eddy","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.115.06783","article-title":"Placental growth factor administration abolishes placental ischemia-induced hypertension","volume":"67","author":"Spradley","year":"2016","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.phrs.2009.10.004","article-title":"Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress","volume":"61","author":"Qian","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.placenta.2026.06.010_bib39","doi-asserted-by":"crossref","first-page":"153910","DOI":"10.1016\/j.phymed.2021.153910","article-title":"Luteolin relieves lung cancer-induced bone pain by inhibiting NLRP3 inflammasomes and glial activation in the spinal dorsal horn in mice","volume":"96","author":"Zhou","year":"2022","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/19768354.2022.2104925","article-title":"Luteolin reduces fear, anxiety, and depression in rats with post-traumatic stress disorder","volume":"26","author":"Sur","year":"2022","journal-title":"Anim Cells Syst (Seoul)"},{"key":"10.1016\/j.placenta.2026.06.010_bib41","doi-asserted-by":"crossref","first-page":"9783893","DOI":"10.1155\/2017\/9783893","article-title":"Luteolin treatment protects against renal ischemia-reperfusion injury in rats","volume":"2017","author":"Hong","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib42","doi-asserted-by":"crossref","first-page":"330 e1","DOI":"10.1016\/j.ajog.2011.01.049","article-title":"Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance","volume":"204","author":"Tam Tam","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5728","key":"10.1016\/j.placenta.2026.06.010_bib43","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.placenta.2026.06.010_bib44","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1172\/JCI70431","article-title":"Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state","volume":"123","author":"Romero","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.placenta.2026.06.010_bib45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib46","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/j.2040-4603.2021.tb00148.x","article-title":"Preeclampsia: linking placental ischemia with maternal endothelial and vascular dysfunction","volume":"11","author":"Bakrania","year":"2020","journal-title":"Compr. Physiol."},{"issue":"6","key":"10.1016\/j.placenta.2026.06.010_bib47","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.115.05883","article-title":"Placental-specific sFLT-1 e15a protein is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity","volume":"66","author":"Palmer","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.placenta.2026.06.010_bib48","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young investigator award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2026.06.010_bib49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.120.15338","article-title":"Total versus free placental growth factor levels in the pathogenesis of Preeclampsia","volume":"76","author":"Lecarpentier","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.placenta.2026.06.010_bib50","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"issue":"S 01","key":"10.1016\/j.placenta.2026.06.010_bib51","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1055\/s-0040-1709696","article-title":"Evaluation of the prognostic value of the sFlt-1\/PlGF ratio in early-onset preeclampsia","volume":"38","author":"Tasta","year":"2021","journal-title":"Am. J. Perinatol."},{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.placenta.2026.06.010_bib53","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/bmj.p1594","article-title":"Pre-eclampsia: FDA approves blood test to identify pregnant women at risk","volume":"382","author":"Tanne","year":"2023","journal-title":"Bmj"},{"key":"10.1016\/j.placenta.2026.06.010_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","author":"Turanov","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.placenta.2026.06.010_bib55","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.placenta.2026.06.010_bib56","doi-asserted-by":"crossref","first-page":"110122","DOI":"10.1016\/j.biopha.2020.110122","article-title":"The bioflavonoid quercetin improves pathophysiology in a rat model of preeclampsia","volume":"127","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib57","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12944-020-01357-w","article-title":"Quercetin attenuates reduced uterine perfusion pressure -induced hypertension in pregnant rats through regulation of endothelin-1 and endothelin-1 type A receptor","volume":"19","author":"Sun","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.placenta.2026.06.010_bib58","doi-asserted-by":"crossref","first-page":"108001","DOI":"10.1016\/j.intimp.2021.108001","article-title":"The natural compound puerarin alleviates inflammation and apoptosis in experimental cell and rat preeclampsia models","volume":"99","author":"Liang","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.placenta.2026.06.010_bib59","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.2353\/ajpath.2010.090800","article-title":"Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction","volume":"177","author":"Tal","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.placenta.2026.06.010_bib60","doi-asserted-by":"crossref","first-page":"115044","DOI":"10.1016\/j.bcp.2022.115044","article-title":"Luteolin binds Src, promotes STAT3 protein ubiquitination and exerts anti-melanoma effects in cell and mouse models","volume":"200","author":"Li","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.placenta.2026.06.010_bib61","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1096\/fj.04-3099fje","article-title":"STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells","volume":"19","author":"Jung","year":"2005","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.placenta.2026.06.010_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049194","article-title":"Luteolin induces carcinoma cell apoptosis through binding Hsp90 to suppress constitutive activation of STAT3","volume":"7","author":"Fu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib63","doi-asserted-by":"crossref","first-page":"17375","DOI":"10.1038\/s41598-018-35745-1","article-title":"HIF-2\u03b1, but not HIF-1\u03b1, mediates hypoxia-induced up-regulation of Flt-1 gene expression in placental trophoblasts","volume":"8","author":"Sasagawa","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.placenta.2026.06.010_bib64","doi-asserted-by":"crossref","first-page":"15222","DOI":"10.1096\/fj.202001681R","article-title":"Hypoxia-inducible factor 2 alpha impairs human cytotrophoblast syncytialization: new insights into placental dysfunction and fetal growth restriction","volume":"34","author":"Colson","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.placenta.2026.06.010_bib65","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3389\/fphar.2018.01094","article-title":"Luteolin prevents cardiometabolic alterations and vascular dysfunction in mice with HFD-induced obesity","volume":"9","author":"Gentile","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.placenta.2026.06.010_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0042-1742317","article-title":"Expression of Endothelin-1 and endothelial nitric oxide synthase in normal and preeclamptic placentae","volume":"44","author":"Khaing","year":"2022","journal-title":"Rev. Bras. Ginecol. Obstet."},{"issue":"25","key":"10.1016\/j.placenta.2026.06.010_bib67","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1080\/14767058.2021.1879785","article-title":"Pravastatin suppresses inflammatory cytokines and endothelial activation in patients at risk of developing preeclampsia: INOVASIA study","volume":"35","author":"Akbar","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib68","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1159\/000482004","article-title":"Plasma ET-1 concentrations are elevated in pregnant women with hypertension -Meta-Analysis of clinical studies","volume":"42","author":"Lu","year":"2017","journal-title":"Kidney Blood Press. Res."},{"issue":"2","key":"10.1016\/j.placenta.2026.06.010_bib69","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/HYPERTENSIONAHA.109.141473","article-title":"Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats","volume":"55","author":"Murphy","year":"2010","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.placenta.2026.06.010_bib70","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/HYPERTENSIONAHA.113.01648","article-title":"Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy","volume":"62","author":"Brewer","year":"2013","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.placenta.2026.06.010_bib71","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/ajh.2011.99","article-title":"Endothelin: key mediator of hypertension in preeclampsia","volume":"24","author":"George","year":"2011","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.placenta.2026.06.010_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/nu15020462","article-title":"A nutraceutical containing chlorogenic acid and Luteolin improves cardiometabolic parameters in subjects with pre-obesity: a 6-Month randomized, double-blind, placebo-controlled study","volume":"15","author":"Terzo","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.placenta.2026.06.010_bib73","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.clinthera.2013.04.006","article-title":"An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders","volume":"35","author":"Taliou","year":"2013","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.placenta.2026.06.010_bib74","doi-asserted-by":"crossref","first-page":"H89","DOI":"10.1152\/ajpheart.00056.2024","article-title":"Reduced uterine perfusion pressure as a model for preeclampsia and fetal growth restriction in murine: a systematic review and meta-analysis","volume":"327","author":"van Kammen","year":"2024","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.placenta.2026.06.010_bib75","article-title":"Longitudinal 3D-DCE MRI assessment of placental perfusion under reduced uterine perfusion pressure in pregnant rats","volume":"39","author":"Al Darwish","year":"2026","journal-title":"NMR Biomed."},{"issue":"2","key":"10.1016\/j.placenta.2026.06.010_bib76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ydbio.2016.12.013","article-title":"Inactivation of maternal Hif-1\u03b1 at mid-pregnancy causes placental defects and deficits in oxygen delivery to the fetal organs under hypoxic stress","volume":"422","author":"Kenchegowda","year":"2017","journal-title":"Dev. Biol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426002997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426002997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:45:03Z","timestamp":1786092303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400426002997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":76,"alternative-id":["S0143400426002997"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2026.06.010","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}